ArticleNature communications2025
Interface preassembly oriented growth strategy towards flexible crystalline covalent organic framework films for OLEDs.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Interfacial Entropy Drives Crystallization of Covalent Framework Membranes for Precise Ionic Separation.Angewandte Chemie (International ed. in English) · 2026Article
- Electronic Modulation of Flexible Ether Oxygen-Based Covalent Organic Frameworks for Efficient Oxygen Reduction Reaction.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Humidity-Guided In Situ Polymerization for Controlled Formation of Smooth, Oriented Covalent Organic Framework Films.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Unlocking intrinsic TADF in flexible crystalline covalent organic frameworks through nanopore confinement design.Nature communications · 2026Article
- Hybrid Liquid Metal Cathode Enables High-Performance Intrinsically Stretchable OLEDs.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Intrinsically stretchable organic light-emitting-diode with high brightness and stretchability via elastic-microphase-engineered emitter and dual-embedded electrode.Light, science & applications · 2026Article
- Alternating-sequence polymer chain facilitating LiNature communications · 2026Article
- Single-component-based multicolor emissions enabled by symmetry breaking.Nature communications · 2025Article
- Revolutionary "Clip-Off" Strategy for Macrocycles from Covalent Organic Frameworks.Research (Washington, D.C.) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The synthesis of flexible crystalline films for optoelectronic applications remains a significant chemical challenge due to the inherent contradiction between flexibility and crystallinity. The delicate balance between flexibility and crystallinity has long constituted a barrier to the development of high-performance optoelectronic materials. Herein, an interface preassembly oriented growth (IPOG) strategy has been explored to fabricate flexible crystalline covalent organic framework (COF) films with controllable thickness. By synergistically modulating hydrophilic and hydrophobic interactions along with interfacial confinement, a set of uniform and flexible crystalline COF films were successfully synthesized. This achievement unlocks the potential of COFs for device applications in organic light-emitting diodes, leading to unprecedented high-efficiency electroluminescence from COFs. This groundbreaking advancement not only lays the foundation for the progress of COF-based OLEDs but also signifies the advent of an era in the synthesis of flexible crystalline materials, wherein exceptional mechanical properties are seamlessly integrated with superior electronic performance, thus heralding a transformative impact on the landscape of flexible electronics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.